Treatment of Pediatric Gastroenteritis

Hospital admissions for pediatric gastroenteritis per 100,000 population less than 18 years of age

Measure Source

Agency for Healthcare Research and Quality (AHRQ) Prevention Quality Indicators (PQI).

Tables

55 Pediatric gastroenteritis admissions (excluding obstetric and neonatal admissions and transfers from other institutions) per 100,000 population age less than 18 years, 2001, by

Data Source

Agency for Healthcare Research and Quality, Healthcare Cost and Utilization Project, State Inpatient Databases, disparities analysis file.

Denominator

Pediatric U.S. population (under 18 years of age) by subcategory (i.e., race, age group, gender, median household income level, urbanization, and region).

Numerator

Pediatric non-maternal/non-neonatal discharges under age 18 with a principal diagnosis for gastroenteritis, excluding transfers from other institutions.

Comments

Rates are adjusted by age and gender using the total U.S. population for 2000 as the standard population; when reporting is by age, the adjustment is by gender only; when reporting is by gender, the adjustment is by age only.

The disparities analysis file, created specifically for this report to provide national estimates on disparities, consists of weighted records from a sample of hospitals from the following 22 states that participate in HCUP and have high quality race/ethnicity data: AZ, CA, CO, CT, FL, GA, HI, KS, MD, MA, MI, MO, NJ, NY, PA, RI, SC, TN, TX, VA, VT, and WI.

Tables were created using version 2.1, revision 2, of the AHRQ Prevention Quality Indicators software. This measure is referred to as indicator 6 in the AHRQ Prevention Quality Indicators software documentation.

Children age 0-17 who had their height and weight measured by a doctor or other health provider. Adolescents age 13-15 who received 3 or more doses of hepatitis B vaccine.

Return to Contents